Skip to main content
. 2014 Sep 3;35(12):2653–2659. doi: 10.1093/carcin/bgu184

Table II.

Association of selected SNPs on 5p15, 15q25 and 6p21 loci with lung cancer risk by cancer type

Marker (minor allele) Type MAF case/controla P value OR (95% CI)b P het
Chromosome 15q25
 rs16969968 (A) All cancers 0.43/0.36 0.00001 1.38 (1.19, 1.60)
Adenocarcinoma 0.44/0.36 0.0001 1.45 (1.20, 1.74) 0.99
Squamous cell carcinoma 0.44/0.36 0.007 1.45 (1.10, 1.91)
 rs8042374 (G) All cancers 0.19/0.24 0.006 0.78 (0.65, 0.93)
Adenocarcinoma 0.19/0.24 0.032 0.77 (0.61, 0.98) 0.26
Squamous cell carcinoma 0.16/0.24 0.007 0.60 (0.42, 0.87)
 rs8034191c (C) All cancers 0.43/0.35 0.000003 1.42 (1.22, 1.64)
Adenocarcinoma 0.44/0.35 0.00006 1.46 (1.21, 1.77) 0.96
Squamous cell carcinoma 0.44/0.35 0.007 1.45 (1.11, 1.91)
Chromosome 5p15
 rs2736100 (T) All cancers 0.46/0.50 0.056 0.87 (0.75, 1.00)
Adenocarcinoma 0.43/0.50 0.004 0.76 (0.63, 0.92) 0.03
Squamous cell carcinoma 0.52/0.50 0.492 0.91 (0.69, 1.19)
 rs4635969 (T) All cancers 0.19/0.19 0.708 0.97 (0.80, 1.16)
Adenocarcinoma 0.19/0.19 0.796 0.97 (0.76, 1.23) 0.72
Squamous cell carcinoma 0.18/0.19 0.547 0.90 (0.63, 1.28)
 rs402710 (T) All cancers 0.31/0.33 0.339 0.93 (0.79, 1.08)
Adenocarcinoma 0.30/0.33 0.129 0.85 (0.70, 1.05) 0.99
Squamous cell carcinoma 0.31/0.33 0.306 0.86 (0.64, 1.15)
 rs401681 (T) All cancers 0.42/0.44 0.370 0.94 (0.81, 1.08)
Adenocarcinoma 0.41/0.44 0.282 0.91 (0.75, 1.09) 0.73
Squamous cell carcinoma 0.40/0.44 0.248 0.87 (0.64, 1.12)
Chromosome 6p21
 rs3131379 (T) All cancers 0.07/0.10 0.032 0.74 (0.57, 0.98)
Adenocarcinoma 0.08/0.10 0.336 0.85 (0.61, 1.19) 0.68
Squamous cell carcinoma 0.07/0.10 0.266 0.75 (0.45, 1.25)

P het, P value for heterogeneity by histology derived from the Cochran Q test. P values <0.05 are shown in bold. aMinor allele frequency.

bEstimated ORs are for the minor alleles.

cIn LD with rs16969968 (r 2 = 0.9), but directly assayed (not imputed) in cases and controls.